- Report
- December 2024
- 150 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- October 2024
- 180 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 377 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2022
- 103 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- January 2022
- 89 Pages
Global
From €3200EUR$3,592USD£2,775GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- May 2022
- 280 Pages
Global
From €3402EUR$3,565USD£2,851GBP
The Anti Counterfeit Pharmaceutical market is a subset of the Pharmaceutical Packaging industry. It is focused on the development of technologies and solutions to prevent the production and distribution of counterfeit drugs. These solutions include tamper-evident packaging, authentication technologies, and track and trace systems. The goal of these solutions is to ensure that the drugs are safe and effective for consumers.
The Anti Counterfeit Pharmaceutical market is driven by the need to protect consumers from the dangers of counterfeit drugs. Governments and regulatory bodies are also increasingly mandating the use of anti-counterfeit solutions. This has led to increased investment in the development of new technologies and solutions.
Some of the major players in the Anti Counterfeit Pharmaceutical market include AlpVision, Applied DNA Sciences, Authentix, Checkpoint Systems, Impinj, and SICPA. Show Less Read more